Clinical Trials Logo
  1. Home
  2. Graft Failure
  3. NCT04685174

Intraoperative NIRS of Transplanted Kidney for Prediction of Acute and Sub-acute Injury

Graft Failure Clinical Trial

Official title:
Intraoperative Near Infrared Spectroscopy of Transplanted Kidney for Prediction of Acute and Sub-acute Kidney Injury in Transplanted Patients

Clinical Trial Summary

This is a prospective, observational cohort study, designed to explore the use of NIRS in kidney transplants. This study will investigate an association between measurements of intra- operative NIRS and post - operative graft dysfunction as manifested in initiation of renal replacement therapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04685174
Study type Interventional
Source Tel-Aviv Sourasky Medical Center
Contact Orr Goren, Dr
Phone +972527360330
Email org@tlvmc.gov.il
Status Not yet recruiting
Phase Phase 3
Start date January 2021
Completion date March 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03948529 - RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation Phase 2
Completed NCT03663036 - Arthroscopic Superior Capsular Reconstruction With Fascia Lata Autograft - Survivorship of the Autograft Analysis N/A
Not yet recruiting NCT05855707 - Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis Phase 1
Recruiting NCT04967391 - Tumescence in HNC Skin Graft Reconstruction Phase 3
Recruiting NCT02061462 - EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs Phase 1
Completed NCT01970605 - Silver Graft All Comers Registry
Terminated NCT01564095 - TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Phase 2/Phase 3
Terminated NCT00208884 - Terminal Graft Failure N/A
Recruiting NCT04779957 - Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy Phase 2
Terminated NCT04494061 - A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant
Terminated NCT04731298 - Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT. Phase 2
Completed NCT01848249 - Deceased Donor Biomarkers and Recipient Outcomes
Active, not recruiting NCT02556879 - Immunization Anti HLA in the Liver Transplant Recipients (DSATH) N/A
No longer available NCT02026934 - CliniMACS® CD34+ Reagent System for Expanded Access Use N/A
Recruiting NCT00472329 - Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant Phase 2
Completed NCT04542954 - Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Recruiting NCT03717545 - Second Transplantation for Graft Failure N/A
Recruiting NCT03019809 - A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients Phase 2
Recruiting NCT01631058 - Renal Transplantation in the Elderly - nEverOld Study Phase 4
Completed NCT06340607 - Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients